Patents by Inventor Ken-ichi Fuhshuku

Ken-ichi Fuhshuku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pseudoglycolipid and use thereof
    Patent number: 8299223
    Abstract: The invention provides a pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the pseudoglycolipid and the like. The inventive compound is represented by the formula (1), or a salt thereof, wherein each symbol is as defined in the specification.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: October 30, 2012
    Assignee: Riken
    Inventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Ryusuke Nakagawa, Hiroshi Watarai
  • Compound having cyclic structure and use thereof
    Patent number: 8173608
    Abstract: The present invention relates to a compound represented by the following formula (1?) wherein R is an aldopyranose residue, R2 is a C2-18 hydrocarbon group optionally having substituent(s), R3 is an acyl group, X is an oxygen atom, a sulfur atom or —NH—, and p is an integer of 0-4, or a salt thereof. The compound of the present invention has a specific immunoregulatory ability, and is useful for the prophylaxis or treatment of autoimmune diseases and the like.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: May 8, 2012
    Assignee: Riken
    Inventors: Ken-ichi Fuhshuku, Kenji Mori, Takuya Tashiro, Masaru Taniguchi, Ken-ichiro Seino
  • Glycolipid and use thereof
    Patent number: 8163705
    Abstract: The present invention provide a compound represented by the following formula (1) wherein each symbol is as defined in the specification, or a salt thereof. The compound of the present invention and a salt thereof can preferentially induce production of IL-4, which is one kind of cytokines that control action of immunocytes. Therefore, it is useful for the prophylaxis or treatment of autoimmune diseases, infectious diseases and the like, and prophylaxis or treatment of diseases caused by functional promotion of Th1 cells.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: April 24, 2012
    Assignee: Riken
    Inventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Kenichiro Seino
  • NOVEL PSEUDOGLYCOLIPID AND USE THEREOF
    Publication number: 20100062990
    Abstract: The invention provides a pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the pseudoglycolipid and the like. The inventive compound is represented by the formula (1), or a salt thereof, wherein each symbol is as defined in the specification.
    Type: Application
    Filed: February 22, 2008
    Publication date: March 11, 2010
    Applicant: RIKEN
    Inventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Ryusuke Nakagawa, Hiroshi Watarai
  • NOVEL GLYCOLIPID AND USE THEREOF
    Publication number: 20090221516
    Abstract: The present invention provide a compound represented by the following formula (1) wherein each symbol is as defined in the specification, or a salt thereof. The compound of the present invention and a salt thereof can preferentially induce production of IL-4, which is one kind of cytokines that control action of immunocytes. Therefore, it is useful for the prophylaxis or treatment of autoimmune diseases, infectious diseases and the like, and prophylaxis or treatment of diseases caused by functional promotion of Th1 cells.
    Type: Application
    Filed: February 28, 2007
    Publication date: September 3, 2009
    Applicant: RIKEN
    Inventors: Takuya Tashiro, Kenji Mori, Ken-ichi Fuhshuku, Masaru Taniguchi, Kenichiro Seino
  • COMPOUND HAVING CYCLIC STRUCTURE AND USE THEREOF
    Publication number: 20090215707
    Abstract: The present invention relates to a compound represented by the following formula (1?) wherein R is an aldopyranose residue, R2 is a C2-18 hydrocarbon group optionally having substituent(s), R3 is an acyl group, X is an oxygen atom, a sulfur atom or —NH—, and p is an integer of 0-4, or a salt thereof. The compound of the present invention has a specific immunoregulatory ability, and is useful for the prophylaxis or treatment of autoimmune diseases and the like.
    Type: Application
    Filed: March 3, 2006
    Publication date: August 27, 2009
    Applicant: RIKEN
    Inventors: Ken-ichi Fuhshuku, Kenji Mori, Takuya Tashiro, Masaru Taniguchi, Ken-ichiro Seino
  • Nasal Vaccine
    Publication number: 20090214596
    Abstract: The present invention provides a nasal vaccine capable of intranasally inducing an effective immunity reaction. Specifically, the invention provides a nasal vaccine containing a compound having an NKT cell-activating action, particularly a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a compound represented by the formula (II): wherein each symbol is as defined in the specification, and an immunogen in an amount effective for stimulating an immune response.
    Type: Application
    Filed: March 30, 2006
    Publication date: August 27, 2009
    Applicant: RIKEN
    Inventors: Ken-ichiro Seino, Masaru Taniguchi, Takuya Tashiro, Ken-ichi Fuhshuku, Kenji Mori, Hideki Hasegawa